Zobrazeno 1 - 2
of 2
pro vyhledávání: '"E Muruzábal Huarte"'
Autor:
R Vera García, A Irigaray Echarri, E Muruzábal Huarte, J De Carlos Artajo, E. Anda Apiñániz, N Castro Unanua, J.M. Zubiria Gortazar
Publikováno v:
Anales del Sistema Sanitario de Navarra. 43:103-106
Everolimus is an mTOR inhibitor, approved as a treatment for cancer and as an immunosuppressant agent in solid organ transplantation; it frequently produces toxic metabolic effects, particularly of the most severe kind. Its use can cause hyperglycemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66faf35ba395480c73b2d8127eb6328e
https://doi.org/10.23938/assn.0859
https://doi.org/10.23938/assn.0859
Autor:
De Carlos Artajo J; Servicio de Endocrinología y Nutrición. Complejo Hospitalario de Navarra. Pamplona.. decarlosjoaquin@gmail.com., Castro Unanua N, Muruzábal Huarte E, Vera García R, Irigaray Echarri A, Zubiría Gortázar J, Anda Apiñániz E
Publikováno v:
Anales del sistema sanitario de Navarra [An Sist Sanit Navar] 2020 Apr 20; Vol. 43 (1), pp. 103-106. Date of Electronic Publication: 2020 Apr 20.